Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:MNTR OTCMKTS:NSAV OTCMKTS:OPMZ OTCMKTS:PKPH On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMNTRMentor Capital$0.04-10.2%$0.05$0.03▼$0.11$930K-0.7213,094 shs22,591 shsNSAVNet Savings Link$0.00$0.00▼$0.01$1.42M3.042.46 million shsN/AOPMZ1PM Industries$0.00$0.00▼$0.00N/AN/A99.04 million shsN/APKPHPeak Pharmaceuticals$1.00$1.53$0.52▼$9.12$392K0.549,053 shs1 shs7 Stocks to Buy And Hold ForeverEnter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMNTRMentor Capital-10.21%-13.45%+21.07%+20.39%-12.04%NSAVNet Savings Link0.00%0.00%-50.00%-66.67%-98.44%OPMZ1PM Industries0.00%0.00%0.00%0.00%0.00%PKPHPeak Pharmaceuticals0.00%-20.00%0.00%-71.43%-52.38%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationMNTRMentor CapitalN/AN/AN/AN/AN/AN/AN/AN/ANSAVNet Savings LinkN/AN/AN/AN/AN/AN/AN/AN/AOPMZ1PM IndustriesN/AN/AN/AN/AN/AN/AN/AN/APKPHPeak PharmaceuticalsN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMNTRMentor Capital 0.00N/AN/AN/ANSAVNet Savings Link 0.00N/AN/AN/AOPMZ1PM Industries 0.00N/AN/AN/APKPHPeak Pharmaceuticals 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMNTRMentor Capital$7.71M0.12N/AN/A$0.13 per share0.33NSAVNet Savings LinkN/AN/AN/AN/AN/AN/AOPMZ1PM IndustriesN/AN/AN/AN/AN/AN/APKPHPeak PharmaceuticalsN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMNTRMentor Capital-$840K-$0.04N/A∞N/AN/A-28.51%-24.14%N/ANSAVNet Savings LinkN/AN/A0.00N/AN/AN/AN/AN/AN/AOPMZ1PM IndustriesN/AN/A0.00N/AN/AN/AN/AN/AN/APKPHPeak Pharmaceuticals-$160KN/A0.00∞N/AN/AN/A-159.55%N/ALatest PKPH, NSAV, MNTR, and OPMZ EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025MNTRMentor CapitalN/A-$0.01N/A-$0.01N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthMNTRMentor CapitalN/AN/AN/AN/AN/ANSAVNet Savings LinkN/AN/AN/AN/AN/AOPMZ1PM IndustriesN/AN/AN/AN/AN/APKPHPeak PharmaceuticalsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMNTRMentor CapitalN/A17.5917.59NSAVNet Savings LinkN/AN/AN/AOPMZ1PM IndustriesN/AN/AN/APKPHPeak PharmaceuticalsN/A0.150.15Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMNTRMentor CapitalN/ANSAVNet Savings LinkN/AOPMZ1PM IndustriesN/APKPHPeak PharmaceuticalsN/AInsider OwnershipCompanyInsider OwnershipMNTRMentor Capital23.73%NSAVNet Savings Link0.19%OPMZ1PM IndustriesN/APKPHPeak Pharmaceuticals18.40%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMNTRMentor Capital221.69 million16.54 millionNot OptionableNSAVNet Savings Link17.10 billion7.09 billionNot OptionableOPMZ1PM Industries2N/AN/ANot OptionablePKPHPeak Pharmaceuticals1392,000320,000Not OptionablePKPH, NSAV, MNTR, and OPMZ HeadlinesRecent News About These CompaniesAkari Therapeutics Merges with Peak Bio for GrowthNovember 9, 2024 | markets.businessinsider.comNetflix hit series Wednesday season 2 is a ‘cultural juggernaut’ that’s already breaking recordsNovember 4, 2024 | msn.comHow are pharmaceutical drug compounds separated?October 2, 2024 | news-medical.netNPiramal Pharma Solutions Plans $80M Expansion for Kentucky FacilityOctober 1, 2024 | genengnews.comGPhathom's Voquezna: A Breakthrough Drug Facing Marketing ChallengesSeptember 27, 2024 | seekingalpha.comThailand says mpox case recorded in traveller from AfricaAugust 22, 2024 | msn.comPharma stocks soar after WHO declares mpox public health emergencyAugust 20, 2024 | msn.comDaytime and early peak commissioningMay 2, 2024 | bbc.co.ukKingswood Capital Management Acquires PATCO ProductsApril 8, 2024 | preparedfoods.comPAkari Therapeutics Signs Merger-of-Equals with Peak BioMarch 5, 2024 | marketwatch.comAkari Therapeutics, Peak Bio Announces Agreement To Merge As Equals - Quick FactsMarch 5, 2024 | markets.businessinsider.comVote NowFebruary 19, 2024 | cbc.caBuy Rating Affirmed for Longboard Pharmaceuticals Amid Strong Bexicaserin Phase 2 Results and Blockbuster Revenue PotentialJanuary 9, 2024 | markets.businessinsider.comShares of Mankind Pharma Fall as Stakeholders Consider Reducing HoldingsDecember 12, 2023 | claytoncountyregister.comCHallowed Peak: Lunar FestivalOctober 31, 2023 | timeout.comTPeak Practice is axedJune 14, 2023 | dailymail.co.ukIs Peak Pharmaceuticals Inc (RMHI) Stock a Good Investment?June 6, 2023 | aaii.comAPeak Pharmaceuticals & Retrieve Medical Announce Signed Contract with Regional Medical CenterMay 31, 2023 | benzinga.comPeak Pharmaceuticals & Retrieve Medical Announce Signed Contract with Regional Medical CenterMay 31, 2023 | finance.yahoo.comMinnesota patients and providers navigate ‘historical peak’ of drug shortagesMay 5, 2023 | mprnews.orgMNew MarketBeat Followers Over TimeMedia Sentiment Over TimePKPH, NSAV, MNTR, and OPMZ Company DescriptionsMentor Capital OTCMKTS:MNTR$0.04 0.00 (-10.21%) As of 07/16/2025 02:26 PM EasternMentor Capital, Inc. is a private equity firm specializing in acquisitions and emerging growth investments. The firm provides passive equity funding and liquidity to smaller companies and owners in the medical, marijuana and social use cannabis companies. It invests in shelf IPO's and public and private companies and seeks to provide public market access to owners of small private companies. The firm specializes in pre-IPO investments in Cannabis companies. It seeks to invest in energy sector of oil and gas, coal, uranium. In case of shelf IPO's, the firm prefers to invest in companies with sales greater than $40 million. It prefers to take significant position in its portfolio companies. The firm invests only in companies that have earnings. Mentor Capital, Inc. was founded in 1985 and is based in Plano, Texas.Net Savings Link OTCMKTS:NSAVNet Savings Link, Inc. operates as a cryptocurrency, blockchain, and digital asset technology company. It holds interests in Cryptocurrency Trading Platform based on Artificial Intelligence (AI) and offers a range of trading services, such as portfolio management and price search function. This platform supports various cryptocurrency exchanges. The company is based in London, the United Kingdom.1PM Industries OTCMKTS:OPMZ1PM Industries, Inc. focuses on the sale and distribution of medical marijuana under the brand Von Baron Farms. It sells products, including its pancake and waffle batter. The company was incorporated in 1990 and is based in Las Vegas, Nevada.Peak Pharmaceuticals OTCMKTS:PKPH$1.00 0.00 (0.00%) As of 07/16/2025Peak Pharmaceuticals, Inc. manufactures and markets pharmaceutical level products containing phytocannabinoids, an abundant and pharmaceutically active component of industrial hemp for the prevention and alleviation of various conditions and diseases. The company was founded on December 18, 2007 and is headquartered in Scottsdale, AZ. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas High-Flying GE Aerospace Drops After Blowout Q2 — What Now? A New $70 Billion AI Investment Could Push Taiwan Semiconductor Why Prologis May Be the Smartest Backdoor Bet on AI Real Estate Is Amazon Really the Best Forever Stock for Your Portfolio? Qualcomm: Undervalued Chip Stock in Breakout Uptrend Broadcom’s Takes on NVIDIA: Why Tomahawk Ultra Could Boost Shares CrowdStrike Bulls Beware: This Trade May Be Getting Crowded AMD Just Triggered a Signal Traders Can’t Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
